CL2014001172A1 - Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo - Google Patents

Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo

Info

Publication number
CL2014001172A1
CL2014001172A1 CL2014001172A CL2014001172A CL2014001172A1 CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1 CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A CL2014001172 A CL 2014001172A CL 2014001172 A1 CL2014001172 A1 CL 2014001172A1
Authority
CL
Chile
Prior art keywords
carrier
active agent
release
encapsulates
nucleus
Prior art date
Application number
CL2014001172A
Other languages
English (en)
Inventor
Patrick A C Gane
Patrick Schwarzentruber
Joachim Schoelkopf
Nicola Maiuta
Catherine Jean Ridgway
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014001172(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of CL2014001172A1 publication Critical patent/CL2014001172A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
CL2014001172A 2011-11-10 2014-05-06 Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo CL2014001172A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
US201161559253P 2011-11-14 2011-11-14

Publications (1)

Publication Number Publication Date
CL2014001172A1 true CL2014001172A1 (es) 2014-09-12

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001172A CL2014001172A1 (es) 2011-11-10 2014-05-06 Un portador para la liberacion controlada de agentes activos que comprende un nucleo de cabonato de calcio y un agente activo, y un recubrimiento que encapsula al nucleo; metodo para preparar el portador, y su uso en controlar la liberacion de un agente activo

Country Status (25)

Country Link
US (1) US9579291B2 (es)
EP (1) EP2747752B1 (es)
KR (1) KR101612655B1 (es)
CN (1) CN103957893B (es)
AU (1) AU2012334082B2 (es)
BR (1) BR112014011310B1 (es)
CA (1) CA2851069C (es)
CL (1) CL2014001172A1 (es)
CO (1) CO6940430A2 (es)
DK (1) DK2747752T3 (es)
ES (1) ES2553091T3 (es)
IL (1) IL231959A0 (es)
IN (1) IN2014MN00843A (es)
MX (1) MX346884B (es)
MY (1) MY168425A (es)
PH (1) PH12014500750A1 (es)
PL (1) PL2747752T3 (es)
PT (1) PT2747752E (es)
RU (2) RU2018123688A (es)
SG (1) SG11201401350WA (es)
SI (1) SI2747752T1 (es)
SM (1) SMT201600010B (es)
TW (1) TWI625129B (es)
WO (1) WO2013068478A1 (es)
ZA (1) ZA201403611B (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2719376T3 (en) 2012-10-12 2015-06-15 Omya Int Ag Gastroretentiv drug formulation and delivery systems and their method of preparation by the use of functional calcium carbonate
CA2899936A1 (en) * 2013-02-15 2014-08-21 Wellmark International Mineral feed-through formulation
EP3103844B1 (en) 2015-06-10 2018-08-08 Omya International AG Use of surface-reacted calcium carbonate as anti-blocking agent
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
US11622929B2 (en) 2016-03-08 2023-04-11 Living Proof, Inc. Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
EP3681921A2 (en) 2017-09-13 2020-07-22 Living Proof, Inc. Color protectant compositions
EP3681920B1 (en) 2017-09-13 2025-06-25 Living Proof, Inc. Long lasting cosmetic compositions
WO2019072877A1 (en) 2017-10-10 2019-04-18 Capsugel Belgium Nv GETTING MULTIPARTICULAR COMPOSITIONS
AU2018370210B2 (en) 2017-11-20 2024-09-26 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
EP3784711A1 (en) 2018-04-27 2021-03-03 Living Proof, Inc. Long lasting cosmetic compositions
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR102936013B1 (ko) 2019-12-03 2026-03-10 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2025132417A1 (en) 2023-12-19 2025-06-26 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery
EP4741032A1 (en) 2024-11-07 2026-05-13 Evonik Operations GmbH Performance enhancement of defoamer formulations via a matrix encapsulation strategy

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
EP1974807B1 (en) 2007-03-21 2010-03-03 Omya Development Ag Process for the removal of endocrine disrupting compounds
DK2070991T3 (da) 2007-12-12 2010-12-20 Omya Development Ag Fremgangsmåde til frembringelse af overflademodificeret, udfældet calciumcarbonat
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
PL2421508T3 (pl) 2009-04-24 2017-06-30 Omya International Ag Materiał w postaci cząstek do kontrolowanego uwalniania składników czynnych
SI2264109T1 (sl) 2009-06-15 2012-07-31 Omya Development Ag Postopek za pripravo površinsko reakcijsko obdelanega kalcijevega karbonata in njegova uporaba
PT2264108E (pt) 2009-06-15 2012-05-23 Omya Development Ag Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco

Also Published As

Publication number Publication date
IL231959A0 (en) 2014-05-28
AU2012334082B2 (en) 2015-10-29
NZ623515A (en) 2016-09-30
CA2851069C (en) 2016-05-31
AU2012334082A1 (en) 2014-04-24
DK2747752T3 (en) 2016-01-18
BR112014011310A2 (pt) 2017-05-09
PL2747752T3 (pl) 2016-04-29
RU2018123688A3 (es) 2022-01-24
PT2747752E (pt) 2016-02-08
KR20140091054A (ko) 2014-07-18
MX346884B (es) 2017-04-05
SMT201600010B (it) 2016-02-25
ZA201403611B (en) 2015-07-29
MX2014005466A (es) 2014-08-22
ES2553091T3 (es) 2015-12-04
WO2013068478A1 (en) 2013-05-16
EP2747752B1 (en) 2015-10-07
CN103957893A (zh) 2014-07-30
BR112014011310B1 (pt) 2022-04-12
EP2747752A1 (en) 2014-07-02
IN2014MN00843A (es) 2015-07-03
SG11201401350WA (en) 2014-05-29
RU2665382C1 (ru) 2018-08-29
US20140248340A1 (en) 2014-09-04
CA2851069A1 (en) 2013-05-16
SI2747752T1 (sl) 2015-12-31
TW201328709A (zh) 2013-07-16
PH12014500750A1 (en) 2014-05-12
CN103957893B (zh) 2017-08-15
US9579291B2 (en) 2017-02-28
MY168425A (en) 2018-11-09
TWI625129B (zh) 2018-06-01
KR101612655B1 (ko) 2016-04-14
CO6940430A2 (es) 2014-05-09
RU2018123688A (ru) 2019-03-07

Similar Documents

Publication Publication Date Title
BR112014011310A2 (pt) carreador para a liberação controlada de um agente ativo, métodos para preparar um carreador, para transportar um agente ativo, método para a liberação controlada de um agente ativo, e para proteger agentes ativos sensíveis ao calor, e, uso de um carreador
CL2014002283A1 (es) Forma de dosificacion oral solida de liberacion inmediata que comprende particulas que comprenden un nucleo con un primer agente activo, un recubrimiento con un segundo agente activo sobre el y un material sensible al ph acido sobre dicho nucleo recubierto; proceso para prepararla; metodo de tratamiento; y uso para tratar dolor.
SG11201406514RA (en) Structures and methods for controlling fragrance release using encapsulated fragrance on container bodies
BRPI0920383A2 (pt) método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia
ZA201209424B (en) Method for delivering an active agent
BR112013018876A2 (pt) dispositivo de travamento, dispositivo de transferência com o mesmo, e método para controlar o dispositivo de travamento
SI3172964T1 (sl) Sestavki proti parazitom, ki obsegajo izoksazolinsko aktivno sredstvo, postopek in njihove uporabe
BRPI0912252A2 (pt) dispositivos oftálmicos para liberação controlada de agentes ativos.
PL2661798T3 (pl) Sposób komunikacji, komunikacyjny system i zawierający go system magazynowania energii
BR112012025375A2 (pt) compósito absorvente, artigo de cuidade pessoal absorvente e método para preparação de um artigo de cuidado pessoal absorvente
CL2013002504A1 (es) Preparacion farmaceutica solida recubierta que comprende a lo menos un ingrediente activo y porque el recubrimiento tiene un espesor de 0,1 a 100nm, de preferencia de 0,3 a 50 nm y mas preferentemente de 0,5 a 35 nm; y su metodo de preparacion
WO2012080833A3 (en) Controlled release dosage forms
BR112013014169A2 (pt) composição para uso em cápsulas de moldagem por revestimento externo e método de formação da composição
BR112012031981A2 (pt) composição aquosa de ingrediente ativo, processo, uso, método para controlar fungos fitopatogênicos e semente
PL2770827T3 (pl) Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna
PL2905268T3 (pl) Kompozycja do traktowania stref zaszpachlowanych gipsem, wykańczanych gipsem albo tynkowanych gipsem i jej zastosowanie do traktowania stref zaszpachlowanych gipsem, wykańczanych gipsem albo tynkowanych gipsem
BR112013022411A2 (pt) artigo absorvente e método para preparar um artigo absorvente
BR112013014540A2 (pt) artigo absorvente e método para preparar o mesmo
PL2872187T3 (pl) Opatrunek z kontrolowanym uwalnianiem substancji czynnych
CL2013002026A1 (es) Compuesto solido (r)-1-etil-3-[5-[2-(1-hidroxi-1-metil-etil)pirimidin-5-il]-7-(tetrahidrofuran-2-il)-1h-benzimidazol-2-il]-urea y metodo para prepararla.
LT2616329T (lt) Laivas su energijos tiekimo sistema ir energijos tiekimo sistemos valdymo būdas
CL2013002903A1 (es) Composicion que comprende azadiractina; metodo para el tratamiento anti-macroincrustacion de al menos un polimeros; y su uso.
BR112013009347A2 (pt) composição, uso de um composto, método para produzir uma camada de liberação adesiva, agente de liberação e película de liberação.
ITTO20120461A1 (it) Agente per il controllo di ectoparassiti di animali.
EP2825040A4 (en) PROCESS FOR PREPARING BENZAZOQUOOLIUM (BQS) SALTS, USE OF THE COMPOSITION AS CELLULAR MARKERS AND USE OF THE BIOLOGICAL ACTIVITY OF THIS COMPOSITION